220 related articles for article (PubMed ID: 12045264)
1. Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations.
Orange JS; Brodeur SR; Jain A; Bonilla FA; Schneider LC; Kretschmer R; Nurko S; Rasmussen WL; Köhler JR; Gellis SE; Ferguson BM; Strominger JL; Zonana J; Ramesh N; Ballas ZK; Geha RS
J Clin Invest; 2002 Jun; 109(11):1501-9. PubMed ID: 12045264
[TBL] [Abstract][Full Text] [Related]
2. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling.
Döffinger R; Smahi A; Bessia C; Geissmann F; Feinberg J; Durandy A; Bodemer C; Kenwrick S; Dupuis-Girod S; Blanche S; Wood P; Rabia SH; Headon DJ; Overbeek PA; Le Deist F; Holland SM; Belani K; Kumararatne DS; Fischer A; Shapiro R; Conley ME; Reimund E; Kalhoff H; Abinun M; Munnich A; Israël A; Courtois G; Casanova JL
Nat Genet; 2001 Mar; 27(3):277-85. PubMed ID: 11242109
[TBL] [Abstract][Full Text] [Related]
3. A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO).
Zonana J; Elder ME; Schneider LC; Orlow SJ; Moss C; Golabi M; Shapira SK; Farndon PA; Wara DW; Emmal SA; Ferguson BM
Am J Hum Genet; 2000 Dec; 67(6):1555-62. PubMed ID: 11047757
[TBL] [Abstract][Full Text] [Related]
4. A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency.
Courtois G; Smahi A; Reichenbach J; Döffinger R; Cancrini C; Bonnet M; Puel A; Chable-Bessia C; Yamaoka S; Feinberg J; Dupuis-Girod S; Bodemer C; Livadiotti S; Novelli F; Rossi P; Fischer A; Israël A; Munnich A; Le Deist F; Casanova JL
J Clin Invest; 2003 Oct; 112(7):1108-15. PubMed ID: 14523047
[TBL] [Abstract][Full Text] [Related]
5. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected].
Wu CJ; Conze DB; Li T; Srinivasula SM; Ashwell JD
Nat Cell Biol; 2006 Apr; 8(4):398-406. PubMed ID: 16547522
[TBL] [Abstract][Full Text] [Related]
6. Anhidrotic ectodermal dysplasia and immunodeficiency: the role of NEMO.
Carrol ED; Gennery AR; Flood TJ; Spickett GP; Abinun M
Arch Dis Child; 2003 Apr; 88(4):340-1. PubMed ID: 12651765
[TBL] [Abstract][Full Text] [Related]
7. Immunodeficiency in Two Female Patients with Incontinentia Pigmenti with Heterozygous NEMO Mutation Diagnosed by LPS Unresponsiveness.
Ohnishi H; Kishimoto Y; Taguchi T; Kawamoto N; Nakama M; Kawai T; Nakayama M; Ohara O; Orii K; Fukao T
J Clin Immunol; 2017 Aug; 37(6):529-538. PubMed ID: 28702714
[TBL] [Abstract][Full Text] [Related]
8. Human nuclear factor kappa B essential modulator mutation can result in immunodeficiency without ectodermal dysplasia.
Orange JS; Levy O; Brodeur SR; Krzewski K; Roy RM; Niemela JE; Fleisher TA; Bonilla FA; Geha RS
J Allergy Clin Immunol; 2004 Sep; 114(3):650-6. PubMed ID: 15356572
[TBL] [Abstract][Full Text] [Related]
9. The presentation and natural history of immunodeficiency caused by nuclear factor kappaB essential modulator mutation.
Orange JS; Jain A; Ballas ZK; Schneider LC; Geha RS; Bonilla FA
J Allergy Clin Immunol; 2004 Apr; 113(4):725-33. PubMed ID: 15100680
[TBL] [Abstract][Full Text] [Related]
10. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia.
Jain A; Ma CA; Liu S; Brown M; Cohen J; Strober W
Nat Immunol; 2001 Mar; 2(3):223-8. PubMed ID: 11224521
[TBL] [Abstract][Full Text] [Related]
11. Specific NEMO mutations impair CD40-mediated c-Rel activation and B cell terminal differentiation.
Jain A; Ma CA; Lopez-Granados E; Means G; Brady W; Orange JS; Liu S; Holland S; Derry JM
J Clin Invest; 2004 Dec; 114(11):1593-602. PubMed ID: 15578091
[TBL] [Abstract][Full Text] [Related]
12. A point mutation in NEMO associated with anhidrotic ectodermal dysplasia with immunodeficiency pathology results in destabilization of the oligomer and reduces lipopolysaccharide- and tumor necrosis factor-mediated NF-kappa B activation.
Vinolo E; Sebban H; Chaffotte A; Israël A; Courtois G; Véron M; Agou F
J Biol Chem; 2006 Mar; 281(10):6334-48. PubMed ID: 16379012
[TBL] [Abstract][Full Text] [Related]
13. Congenital alterations of NEMO glutamic acid 223 result in hypohidrotic ectodermal dysplasia and immunodeficiency with normal serum IgG levels.
Karamchandani-Patel G; Hanson EP; Saltzman R; Kimball CE; Sorensen RU; Orange JS
Ann Allergy Asthma Immunol; 2011 Jul; 107(1):50-6. PubMed ID: 21704885
[TBL] [Abstract][Full Text] [Related]
14. Defective nuclear IKKα function in patients with ectodermal dysplasia with immune deficiency.
Temmerman ST; Ma CA; Zhao Y; Keenan J; Aksentijevich I; Fessler M; Brown MR; Knutsen A; Shapiro R; Jain A
J Clin Invest; 2012 Jan; 122(1):315-26. PubMed ID: 22156202
[TBL] [Abstract][Full Text] [Related]
15. EDA-ID and IP, two faces of the same coin: how the same IKBKG/NEMO mutation affecting the NF-κB pathway can cause immunodeficiency and/or inflammation.
Fusco F; Pescatore A; Conte MI; Mirabelli P; Paciolla M; Esposito E; Lioi MB; Ursini MV
Int Rev Immunol; 2015; 34(6):445-59. PubMed ID: 26269396
[TBL] [Abstract][Full Text] [Related]
16. A role for NF-kappaB essential modifier/IkappaB kinase-gamma (NEMO/IKKgamma) ubiquitination in the activation of the IkappaB kinase complex by tumor necrosis factor-alpha.
Tang ED; Wang CY; Xiong Y; Guan KL
J Biol Chem; 2003 Sep; 278(39):37297-305. PubMed ID: 12867425
[TBL] [Abstract][Full Text] [Related]
17. Transient hemophagocytosis with deficient cellular cytotoxicity, monoclonal immunoglobulin M gammopathy, increased T-cell numbers, and hypomorphic NEMO mutation.
Pachlopnik Schmid JM; Junge SA; Hossle JP; Schneider EM; Roosnek E; Seger RA; Gungor T
Pediatrics; 2006 May; 117(5):e1049-56. PubMed ID: 16636116
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cells from humans with hypomorphic mutations in IKBKG/NEMO have impaired mitogen-activated protein kinase activity.
Ma CA; Wang HY; Temmerman S; Zhao Y; Wu L; Hornung RL; Wara D; Jain A
Hum Mutat; 2011 Mar; 32(3):318-24. PubMed ID: 21309033
[TBL] [Abstract][Full Text] [Related]
19. X-linked ectodermal dysplasia and immunodeficiency caused by reversion mosaicism of NEMO reveals a critical role for NEMO in human T-cell development and/or survival.
Nishikomori R; Akutagawa H; Maruyama K; Nakata-Hizume M; Ohmori K; Mizuno K; Yachie A; Yasumi T; Kusunoki T; Heike T; Nakahata T
Blood; 2004 Jun; 103(12):4565-72. PubMed ID: 14726382
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and treatment in anhidrotic ectodermal dysplasia with immunodeficiency.
Kawai T; Nishikomori R; Heike T
Allergol Int; 2012 Jun; 61(2):207-17. PubMed ID: 22635013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
